Elaine J. Heron - Jun 3, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Jun 3, 2024
Transactions value $
-$11
Form type
4
Date filed
6/4/2024, 07:29 PM
Previous filing
May 23, 2024
Next filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $318K +5.05K +5.21% $63.10 102K Jun 3, 2024 Direct
transaction BMRN Common Stock Tax liability -$318K -4.17K -4.09% $76.41 97.7K Jun 3, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -5.05K -100% $0.00* 0 Jun 3, 2024 Common Stock 5.05K $63.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.